NCT05247112 Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
| NCT ID | NCT05247112 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | Helicobacter Pylori Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2003-07-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2003-07-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.
Eligibility Criteria
Inclusion Criteria: * Subjects who had a H. pylori infection and had consented to undergo culture analysis via endoscopic resection, in order to determine the minimal inhibitory concentration (MIC) of various antibiotics. Exclusion Criteria: * Patients with a concurrent critical illness, who abused drugs or alcohol, who were pregnant or nursing, or those who had received antibiotics, PPIs, or bismuth salts within 4 weeks, were excluded.
Contact & Investigator
Nayoung Kim, M.D., Ph.D
STUDY CHAIR
Seoul National University Bundang Hospital
Frequently Asked Questions
Who can join the NCT05247112 clinical trial?
This trial is open to participants of all sexes, studying Helicobacter Pylori Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05247112 currently recruiting?
Yes, NCT05247112 is actively recruiting participants. Contact the research team at saludos@naver.com for enrollment information.
Where is the NCT05247112 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT05247112 clinical trial?
NCT05247112 is sponsored by Seoul National University Bundang Hospital. The principal investigator is Nayoung Kim, M.D., Ph.D at Seoul National University Bundang Hospital. The trial plans to enroll 2,000 participants.